High-Resolution Ultrasound

Facilities and Equipment

VisualSonic Vevo 770

Like its predecessor, the Vevo 770 provides the small animal researcher with the ability to visualize and quantify small animal anatomical targets, hemodynamics and therapeutic interventions with resolution down to 30 microns. Because it is non-invasive, longitudinal monitoring and quantification of phenotypes and therapeutic regimes can be monitored in the same animal over time. New functionality now available on the Vevo 770 includes increased temporal resolution, improved workflow and ergonomics, and newly available features — including the release of Power Doppler to visualize and quantify relative microvasculature in vivo for anti-angiogenic studies.

Service

Non-destructive, rapid, high spatial and contrast resolution imaging of live mice that could potentially be done in a sterile environment and without anesthesia, provides a powerful tool to monitor superficial and deep tumors. It is well known that subcutaneous tumors exhibit different vascular morphology without the influence of their native host tissue [1]. Ultrasound provides the ability to detect and monitor deep tumors analogous to physical examination of superficial tumors with minimal risk to the animal. Specific services include:

  • Monitoring of in situ tumor growth
  • Left ventricular volume measurement
  • Imaging in a sterile environment
  • Tumor viability and quantification of relative blood flow and blood volume with contrast media.

Structural In-Vivo Imaging of Live Mice

Breast Tumor

Ultrasound is a practical imaging tool that can image mice in real-time at high frame rates. It is ideally suited at imaging naturally occurring tumors and monitoring their growth (Figure 7) and because of the small size of mice can easily distinguish small intraperitoneal tumors from bowel (Figure 8). Because of the high resolution available at high frequency, it can image the liver of a mouse to detect metastases (Figure 9). Further, the availability of ultrasound contrast media allows the visualization of tumor vessels (Figure 8 & 9). While it is difficult to perform CT and MRI in a sterile environment, ultrasound imaging can be performed in a sterile fashion as is currently done with intra-operative ultrasound. The unit is draped with a sterile, transparent cover allowing access to the unit’s controls and the transducer is placed in a sterile sleeve preventing contamination of the scanning field.

The ultrasound images shown in Figures 7-9 were acquired while the animals were anesthetized. To minimize animal loss due to anesthesia, we will image mice in a sterile fashion but without anesthesia, when no intravenous administration is required. Since nude mice do not require shaving and since ultrasound acquires images in real-time, contact with skin and motion will not hinder the ability to survey the animal’s abdomen. This can be accomplished by having an assistant immobilize the animal by holding it with the dorsal skin, as is done during intraperitoneal injections, by one hand and holding the hind legs to slightly stretch the abdomen by the other. The sonographer can then quickly scan the abdomen to survey for the presence and size of tumors. A non-nude mouse can be anesthetized with Isofluorane, a quick acting anesthetic, to allow for shaving, and then it can be imaged while non-anesthetized. While it can be argued that stress could affect the animals’ physiology, anesthesia has more depressing effects on mice. Nonetheless, imaging without anesthesia is not intended to image physiology that requires contrast administration, rather, it is intended to detect and monitor the anatomy of tumors analogous to a physical exam.

Tumors in the abdomenTumor in mouse

Images acquired using the Matrigel angiogenesis model described were exquisite (Figure 10). They allowed the visualization of the angiogenic vascular plug before ultrasound contrast was administered because of the heterogeneous architecture where vessels developed in the bFGF-impregnated homogeneous Matrigel. When contrast was administered, dramatic enhancement of the perfused vessels occurred (arrows in Figure 10).

Sterile Imaging will be performed by first wiping down the unit with disinfecting solution and wheeling it into the treatment room. Sterile Gel will be placed between the transducer surface and the sterile sleeve covering it and its cable. The unit will be covered with a sterile plastic transparent drape to allow access to its controls. The sonographer will gown and glove according to protocol. For standard monitoring of tumor size, nude mice will be scanned without anesthesia as described above using a small amount of sterile warm gel for contact. When a tumor is detected, images will be acquired with internal landmarks to allow session to session or post mortem confirmation, and tumor dimensions will be measured and images stored digitally.

Functional In-Vivo Imaging of Live Nude Mice

Relative blood flow and fractional blood volume indices can be assessed with ultrasound contrast intermittent imaging [2-5]. Further, we also showed that fractional blood volume, determined by intermittent imaging following long interscan delay using a Vx2 tumor model, correlates with microvascular density, an index of angiogenesis. Therefore, it is possible to determine tumor vascularity and angiogenesis and possibly the effect of anti-angiogenic therapy. Since imaging sessions can be performed repeatedly, particularly if done with quick anesthesia to place an IV line, tumor response to interventions such as an anti-angiogenesis therapy can be monitored as frequently and for as long as desired for longitudinal experiments. Assessing relative blood flow using the destruction model [6] rather than the destruction reperfusion model requires only 2 or 3 seconds without animal motion as compared to 15 sec.




  1. Roberts WG (1998), Delaat J, Nagane M, Huang S, Cavenee WK, Palade GE. Host microvasculature influence on tumor vascular morphology and endothelial geen expression. Amer J Path 153;1239-1248.
  2. Wei K (1998), Jayaweera AR, Firoozan S, et al. Quantification of myocardial blood flow with ultrasound-induced destruction of microbubbles administered as a constant venous infusion. Circulation 97:473-83.
  3. Villanueva FS (2002), Abraham JA, Schreiner GF, et al. Myocardial contrast echocardiography can be used to assess the microvascular response to vascular endothelial growth factor-121. Circulation 105:759-65.
  4. Kono Y (2000), Mattrey RF,Summers H, Baker K, Steinbach G. Visualization of Tumor Vessels with Ultrasound Contrast and the Potential for Quantitative Analysis of Relative Tumor Blood Flow and Fractional Blood Volume. AIUM 44th Annual Convention, San Francisco, J Ultrasound Med 19: S59.
  5. Mattrey RF (1998), Peterson TM, Baker KG, Dieranieh LH, Lee YZ, Steinbach GC: The Use of Ultrasound Contrast to Quantify Kidney Perfusion with B-mode Imaging. RSNA, Chicago, Radiology 209:461.
  6. Lucidarme O (2003), Kono Y, Corbeil J, Choi SH, Mattrey RF. Validation of ultrasound contrast destruction imaging for flow quantification. Ultrasound Med Biol 29:1697-704.